Janssen R And D Drug Patent Portfolio
Janssen R And D owns 1 orange book drug protected by 8 US patents Given below is the list of Janssen R And D's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7037917 | HIV replication inhibiting pyrimidines | 13 Jun, 2021 | Expired |
| US7037917 | HIV replication inhibiting pyrimidines | 13 Dec, 2020 | Expired |
| US6878717 | HIV replication inhibiting pyrimidines | 05 May, 2020 | Expired |
| US8003789 | HIV replication inhibiting pyrimidines | 01 May, 2020 | Expired |
| US6878717 | HIV replication inhibiting pyrimidines | 05 Nov, 2019 | Expired |
| US8003789 | HIV replication inhibiting pyrimidines | 01 Nov, 2019 | Expired |
| US7887845 | Antiviral compositions | 25 Sep, 2019 | Expired |
| US7887845 | Antiviral compositions | 25 Mar, 2019 | Expired |
Latest Legal Activities on Janssen R And D's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Janssen R And D.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Expire Patent
Critical
| 25 Sep, 2023 | US8003789 |
|
Maintenance Fee Reminder Mailed
Critical
| 10 Apr, 2023 | US8003789 |
| 11.5 yr surcharge- late pmt w/in 6 mo, Large Entity | 16 Nov, 2022 | US7887845 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 16 Nov, 2022 | US7887845 |
|
Maintenance Fee Reminder Mailed
Critical
| 03 Oct, 2022 | US7887845 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 07 Feb, 2019 | US8003789 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 02 Aug, 2018 | US7887845 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 19 Oct, 2017 | US7037917 |
| Post Issue Communication - Certificate of Correction | 26 Aug, 2013 | US7037917 |
|
Recordation of Patent Grant Mailed
Critical
| 23 Aug, 2011 | US8003789 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 23 Aug, 2011 | US8003789 |
|
Email Notification
Critical
| 04 Aug, 2011 | US8003789 |
|
Issue Notification Mailed
Critical
| 03 Aug, 2011 | US8003789 |
| Dispatch to FDC | 18 Jul, 2011 | US8003789 |
|
Patent Term Extension Certificate
Critical
| 18 Jul, 2011 | US7037917 |
Janssen R And D's Family Patents
Janssen R And D Drug List
Given below is the complete list of Janssen R And D's drugs and the patents protecting them.
1. Intelence
Intelence is protected by 8 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7037917
(Pediatric)
| HIV replication inhibiting pyrimidines |
13 Jun, 2021
(3 years ago)
| Expired |
| US7037917 | HIV replication inhibiting pyrimidines |
13 Dec, 2020
(4 years ago)
| Expired |
| US6878717
(Pediatric)
| HIV replication inhibiting pyrimidines |
05 May, 2020
(4 years ago)
| Expired |
| US8003789
(Pediatric)
| HIV replication inhibiting pyrimidines |
01 May, 2020
(4 years ago)
| Expired |
| US6878717 | HIV replication inhibiting pyrimidines |
05 Nov, 2019
(5 years ago)
| Expired |
| US8003789 | HIV replication inhibiting pyrimidines |
01 Nov, 2019
(5 years ago)
| Expired |
| US7887845
(Pediatric)
| Antiviral compositions |
25 Sep, 2019
(5 years ago)
| Expired |
| US7887845 | Antiviral compositions |
25 Mar, 2019
(5 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Intelence's drug page